Other
Journal
Breaking News
- NIH Launches Dietary Supplement Label Database
Searchable collection contains label information from supplements sold in U.S. (June 17) - Phase III Trial Evaluates Novel Insulin Inhalation Powder for Type 2 Diabetes
Study results due this summer (June 17) - Osteoporosis Therapy Stops Growth of Breast Cancer Cells
Bazedoxifene may offer new treatment option (June 15) - New Guidelines for Management of Arterial Hypertension
Recommendations introduced at European blood pressure conference (June 14) - Long-Term Data Support Safety Profile of Dabigatran (Pradaxa) for Stroke Prevention
Major bleeding rate less than 4% per year in extension trial (June 14)
Free App
Managed Care, and P&T are available for free on multiple mobile platforms and devices. For Apple and iOS devices, visit the Apple Store and download the free digital application for Managed Care and P&T. Search for "Managed Care," "Pharmacy and Therapeutics," or "MediMedia."
Users of Android, Blackberry, Nook, and Kindle can view the mobile version on their respective devices by visiting these Web sites: Managed Care and P&T.
Resources
Pharmacy Policies/Procedures: Forms and guidelines
Cost Calculators: Exclusive online tools to evaluate your pharmacy costs
Links: A comprehensive map of web links to the world of managed care pharmacy
P&T Community
Update Your Registration Profile
Haven't received your weekly newsletters about the new features on PTcommunity.com? Check your newsletter status by clicking here. Scroll down to the question, 'Check here if you would like to receive our e-newsletter?' and choose 'Yes' or 'No.'
Having trouble with the site? Send an email.
P&T Journal
for June 2013
Features
Pharmacovigilance Forum
Meeting Highlights
48th European Association for the Study of the Liver and American Association for Cancer Research
Departments
Medication Errors
Multiple Brand Names for the Same Generic Drug Can Cause Confusion
Prescription: Washington
Medicare Changes Include New Part D Rules and Possible Cuts to Hospitals
New Drugs/Drug News/New Medical Devices
Pharmaceutical Approval Update
Drug Forecast
About P&T
Welcome from David B. Nash, MD, MBA, Editor-in-Chief
David B. Nash, MD, MBA, is Dean of the Jefferson School of Population Health, Philadelphia. From 1996 to 2003, he served as the first Associate Dean for Health Policy at Jefferson Medical College. In 2004, he was named Co-director of the Masters Program in Public Health at Jefferson.
View the rest of the Editorial Board here.
Contacts:
Editor: ssherritze@medimedia.comAdvertising: mliberti@medimedia.com
Circulation: lgardineer@medimedia.com
Production: wpeart@medimedia.com
Rate Card & Production Specifications
BPA Statement
Call For Papers
P&T Journal is now accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please see our author guidelines below or contact the editor, Sonja Sherritze, via phone 267-685-2779 or email: ssherritze@medimedia.com.Subscribe to P&T
Print Edition
P&T TV
More Will Be Expected of Pharmacists
F. Randy Vogenberg, RPh, PhD, a member of P&T’s Editorial Board, says that in the fixed reimbursement system under health reform, pharmacists will need to balance clinical and economic considerations. The less expensive drug might not always be the answer.Recent Headlines
- FDA’s Cyber Security Team Issues Warning on Medical Devices
Report urges health care facilities to take proactive measures (June 13) - Supreme Court Rules ‘Naturally Occurring’ Human Genes Cannot Be Patented
Synthetic genes are fair game, however (June 13) - Denosumab (Xgeva) Approved to Treat Bone Tumors
New indication updates 2010 labeling (June 13) - Alzheimer’s Drug Trial Halted Because of Liver Problems
Research continues on beta secretase inhibitor (June 13) - Study: Nervous System Plays Key Role in Arthritis
Reducing levels of nerve-growth factor may lead to better pain treatments (June 13) - Tenofovir (Viread) Halves HIV Risk in Intravenous Drug Users
Researchers recommend pre-exposure prophylaxis (June 13) - Study: Gene Variants May Predict Who Will Respond to Breast Cancer Prevention Drugs
Discovery advances individualized care of high-risk women (June 13) - Positive Phase III Results With Tocilizumab (RoACTEMRA) in Early RA
Two studies presented at EULAR congress (June 13) - Report: Cancer Guidelines Do Not Fully Meet IOM Standards
Authors question criteria for best quality of care (June 12) - ‘Stewardship Program’ Helps Pediatricians Limit Misuse of Antibiotics
Clinicians align prescribing with national guidelines (June 12)
